Pharmacogenetics, or Pharmacogenomics, studies our predisposition to drugs. Thanks to this DNA analysis we can ascertain whether one is predisposed to a drug that might be toxic to him, or that has little effect, or too much, and much more.
We have always observed how some drugs have the desired effect on some people, but not on others. There may be many causes that explain these differences, and pharmacogenetics is undoubtedly one of the most important factors.
Our DNA analysis of pharmacogenetics analyses a list of medicines from our genetic map. We operate based on recognised scientific studies widely accepted by the scientific community, to which we apply your genetic data. Checking your genetic data against these studies, our algorithms show us your predisposition to these drugs.
There is more and more talk today about personalised medicine, or precision medicine. Pharmacogenetics is the first step towards individualised medicine, no longer prescribed in an industrialised way. Thanks to it the wrong drugs are no longer prescribed because, with the patient’s genetic data available, we know that they are not the most appropriate for us.
In this new era of personalised medicine, each person is prescribed drugs based on his individual profile, because no two people are the same, and different drugs have different effects on each person. Thanks to DNA analysis of pharmacogenomics, we can confirm your predisposition to several drugs, so that doctors can avoid those that we know it is very likely will produce toxicity, or that simply will not have the desired effect. Thus, doctors will be able to choose the drugs that best suit their patients, and calculate doses in a much smarter way.
Personalised medicine is, at the same time, a fundamental element for reducing costs (and time) for healthcare systems, because the "let's try this medication and if it does not work we'll change it" approach is consistently avoided.
There are medications with which, once prescribed, it takes months to evaluate whether they are having the desired effect or not. In many cases, for the same pathology there are different pharmacological alternatives, and your doctor, having your pharmacological report, will be more likely to get it right.
Our pharmacogenetic report is divided into 5 specialised medical fields: Cardiology, Neurology, Pain, Oncology and others.
These are the drugs that we analyse for
|Oncology||Fluorouracil, capecitabine, pyrimidine analogues, tegafur and Neoplasms|
This report is not valid for clinical or diagnostic use